SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-002307
Filing Date
2013-01-14
Accepted
2013-01-14 16:49:11
Documents
11
Period of Report
2012-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-2046_110q.htm 10-Q 343087
2 EX-31.1 a13-2046_1ex31d1.htm EX-31.1 10227
3 EX-31.2 a13-2046_1ex31d2.htm EX-31.2 10238
4 EX-32.1 a13-2046_1ex32d1.htm EX-32.1 6308
5 EX-32.2 a13-2046_1ex32d2.htm EX-32.2 6289
  Complete submission text file 0001104659-13-002307.txt   1785622

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20121130.xml EX-101.INS 161944
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20121130.xsd EX-101.SCH 17864
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20121130_cal.xml EX-101.CAL 26189
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20121130_def.xml EX-101.DEF 36910
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20121130_lab.xml EX-101.LAB 256821
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20121130_pre.xml EX-101.PRE 118392
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 13528283
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1